Niagen Bioscience, Inc.
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Equivalents | — | — | — | — | — | — |
| Accounts Receivable | $5.3M | $5.9M | $1.9M | $838.8K | $1.9M | $723.7K |
| Inventory | $5.8M | $7.9M | $3.7M | $2.2M | $5.2M | $2.9M |
| Total Current Assets | $57.2M | $15.7M | $9.9M | $5.8M | $7.9M | $5.0M |
| Property, Plant & Equipment | $2.9M | $1.8M | $1.3M | $1.1M | $936.4K | $1.2M |
| Goodwill | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $1.7M | $486.2K | $296.1K | $201.7K | $136.2K | $100.1K |
| Total Assets | $62.7M | $19.8M | $11.5M | $9.0M | $9.0M | $6.3M |
| Liabilities | ||||||
| Accounts Payable | $3.7M | $6.0M | $3.5M | $1.4M | $3.4M | $2.3M |
| Total Current Liabilities | $8.1M | $8.9M | $5.0M | $2.8M | $4.8M | $3.3M |
| Long-Term Debt | — | $0 | $2.0M | — | — | — |
| Total Liabilities | $8.9M | $9.8M | $7.5M | $3.3M | $5.0M | $3.7M |
| Stockholders' Equity | ||||||
| Retained Earnings | $-56.6M | $-45.2M | $-39.5M | $-34.1M | $-29.7M | $-18.1M |
| Total Stockholders' Equity | $53.8M | $10.0M | $4.0M | $5.7M | $4.0M | $2.6M |